Previous editions > Schedule 2022The NeurATRIS 2022 Annual General Meeting took place on December 05, 2022 from 9:00 am to 4:45 pm at the Cité Internationale Universitaire de Paris.
PROGRAM: 09:00 - 09:30 Welcome, coffee 09:30 - 10:30 Session 1 : Review of the 2019 evaluation and perspectives
10:30 - 13:00 Session 2 : Scientific results 10:30 - 11:00 WP1 Cell therapy 10h30 - 10h40: Overview by Anne-Catherine Bachoud Levi and Anselme Perrier 10h40- 10h50: Marine Lunven, NPI-ENS: “New line of Digitalised assessments in cognition in Huntington's disease” 10h50- 11h00: Rachid Riad, LSCP/ NPI-ENS: “Voice analysis for predicting the clinical score in Huntington's disease » 11:00 - 11:30 Coffee break 11:30 - 11:50 WP2 Gene therapy 11h30- 11h40: Overview by Marie-Anne Colle 11h40-11h50: Françoise Piguet, ICM: "Intravenous gene therapy for metachromatic leukodystrophy" 11:50 - 12:30 WP3 Functional analysis and in vivo assessment 11h50- 11h55: Short introduction by Philippe Hantraye 11h55- 12h05: Nadège Sarrazin, ICM:« Failed remyelination of the nonhuman primate optic nerve leads to axon degeneration, retinal damages, and visual dysfunction” 12h05- 12h30: Céline Baligand, CEA-MIRcen: “New methodological developments in oxygen-17 MRI” 12:30 - 13:00 WP4 Drug based therapy 12h30- 12h40: Overview by Brahim Nait Oumesmar 12h40- 12h50: Cindy Bokobza, NeuroDiderot: “Targeting the brain 5-HT7 receptor to prevent hypomyelination in a rodent model of perinatal white matter injuries” 12h50- 13h00: Nadjet Gacem, ICM: “Identification of Novel Repurposing Drugs for Myelin Regeneration Therapeutics in Multiple Sclerosis”
13:00 - 14:00 Lunch
14:00 - 15:15 Session 3 : Selected projects from NeurATRIS Call 14h00- 14h15: Sylvie Remaud, MNHN: “Impact of Endocrine-disrupting chemicals on remyelination” 14h15- 14h30: Brahim Nait Oumesmar, ICM: “Glial Cells Missing transcription factors: An anti-inflammatory function conserved from flies to humans” 14h30- 14h45: Cendra Agulhon, INC: “Satellite glial cell-proprioceptor interactions: implications for spinal muscular atrophy,amyotrophic lateral sclerosis and Friedreich’s ataxia” 14h45- 15h00: Pierre Gressens, NeuroDiderot: “Regulation of microglial activation by omega3: a novel and targetable mechanism in neurodevelopmental disorders” 15h00 - 15h15: Fernanda Marques, ICVS- University of Minho: “Metabolic Reprogramming in the EAE mouse model of Multiple Sclerosis” 15:15 - 15:45 Coffee break 15:45 - 16:30 Presentation of EATRIS, the European Infrastructure for Translational Research by Toni Andreu, EATRIS Scientific Director 16:30 - 16:45 Conclusion by Bernard Zalc, ICM End of the meeting for attendees except COMEX and SAB 16:45 - 17h30 Feedback from SAB and discussion between SAB and NeurATRIS members
|
| Online user: 2 | Privacy |
|
